Advanced practice programs in hospital pharmacy - Investigational drug services

Hospital Pharmacy

Volumn 43, Issue 2, 2008, Pages 143-148

  Mark, Scott M ^a,b   Weber, Robert J ^a,b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEW DRUG;

DRUG RESEARCH; HOSPITAL PHARMACY; HUMAN; INSTITUTIONAL REVIEW; JOB PERFORMANCE; PHARMACIST; PROFESSIONAL PRACTICE; RESPONSIBILITY; REVIEW; WORKLOAD;

EID: 52649091662     PISSN: 00185787     EISSN: None     Source Type: Journal    
DOI: 10.1310/hpj4302-143     Document Type: Review

References (6)

1. Kleinman LM, Tangrea JA, Gallelli JF. Control of investigational drugs in a research hospital. Am J Hosp Pharm. 1974;31(4):368-371.
2. Kleinman LM, Tangrea JA. Involvement of the hospital pharmacist in single- and double-blind studies. Am J Hosp Pharm. 1974;31(10):979-981.
3. Peltzman S. An evaluation of consumer protection legislation: the 1962 drug amendments. J Polit Econ. 1973;81(5):1049-1091.
4. LaFleur J, Tyler LS, Sharma RR. Economic benefits of investigational drug services at an academic institution. Am J Health Syst Pharm. 2004;61(1):27-32. (Pubitemid 39004650)
5. The Food and Drug Administration. Clinical testing for safe and effective drugs, DHEW Publication No. (FDA) 74-3015. US Government Printing Office, Washington, DC.
6. Ansani N, Sirio C, Henderson B, Smitherman T, Weber RJ, Skledar SJ, ZgheibN, Branch RA. Designing a strategy to promote safe innovative off-label use of medications. Am J of Med Qual. 2006;21():246-254. (Pubitemid 44035784)